Search details
1.
Drug-drug conjugates of MEK and Akt inhibitors for RAS-mutant cancers.
Bioorg Med Chem
; 102: 117674, 2024 Mar 15.
Article
in English
| MEDLINE | ID: mdl-38457912
2.
Inhibition of EGFR and MEK surmounts entrectinib resistance in a brain metastasis model of NTRK1-rearranged tumor cells.
Cancer Sci
; 113(7): 2323-2335, 2022 Jul.
Article
in English
| MEDLINE | ID: mdl-35363931
3.
Trametinib overcomes KRAS-G12V-induced osimertinib resistance in a leptomeningeal carcinomatosis model of EGFR-mutant lung cancer.
Cancer Sci
; 112(9): 3784-3795, 2021 Sep.
Article
in English
| MEDLINE | ID: mdl-34145930
4.
Glycogen synthase kinase-3 inhibition overcomes epithelial-mesenchymal transition-associated resistance to osimertinib in EGFR-mutant lung cancer.
Cancer Sci
; 111(7): 2374-2384, 2020 Jul.
Article
in English
| MEDLINE | ID: mdl-32391602
5.
Phase I study of vorinostat with gefitinib in BIM deletion polymorphism/epidermal growth factor receptor mutation double-positive lung cancer.
Cancer Sci
; 111(2): 561-570, 2020 Feb.
Article
in English
| MEDLINE | ID: mdl-31782583
6.
EGFR-TKI resistance promotes immune escape in lung cancer via increased PD-L1 expression.
Mol Cancer
; 18(1): 165, 2019 11 20.
Article
in English
| MEDLINE | ID: mdl-31747941
7.
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance.
Cancer Sci
; 110(10): 3215-3224, 2019 Oct.
Article
in English
| MEDLINE | ID: mdl-31432603
8.
[A Case of Malignant Ameloblastoma Associated with Uncontrollable Hypercalcemia].
Gan To Kagaku Ryoho
; 46(Suppl 1): 55-56, 2019 May.
Article
in Japanese
| MEDLINE | ID: mdl-31189854
9.
[Retrospective Observational Study on Chemical Coping].
Gan To Kagaku Ryoho
; 46(Suppl 1): 60-62, 2019 May.
Article
in Japanese
| MEDLINE | ID: mdl-31189856
10.
[Fentanyl Citrate Sublingual Tablets Were Effective in Relieving Symptoms of Akathisia - A Case Report].
Gan To Kagaku Ryoho
; 45(Suppl 1): 89-91, 2018 Mar.
Article
in Japanese
| MEDLINE | ID: mdl-29650885
11.
[Usefulness of Suvorexant for Complicated Delirium in Cancer Patients Who Experience Sleep Disturbance during Hospitalization].
Gan To Kagaku Ryoho
; 45(Suppl 1): 92-94, 2018 Mar.
Article
in Japanese
| MEDLINE | ID: mdl-29650886
12.
[Assessing Patient Factors Influencing the Discontinuation of Opioids after Intra-Arterial Chemotherapy for Oral Cancer - A Retrospective Study].
Gan To Kagaku Ryoho
; 45(Suppl 1): 95-97, 2018 Mar.
Article
in Japanese
| MEDLINE | ID: mdl-29650887
13.
[Patient Factors Enabling the Decannulation of the Gastrostomy Tube after Superselective Intra-Arterial Chemoradiation Therapy for Locally Advanced Oral Cancer - A Retrospective Study].
Gan To Kagaku Ryoho
; 45(Suppl 1): 104-106, 2018 Mar.
Article
in Japanese
| MEDLINE | ID: mdl-29650890
14.
Impact of MET inhibition on small-cell lung cancer cells showing aberrant activation of the hepatocyte growth factor/MET pathway.
Cancer Sci
; 108(7): 1378-1385, 2017 Jul.
Article
in English
| MEDLINE | ID: mdl-28474864
15.
Amphiregulin triggered epidermal growth factor receptor activation confers in vivo crizotinib-resistance of EML4-ALK lung cancer and circumvention by epidermal growth factor receptor inhibitors.
Cancer Sci
; 108(1): 53-60, 2017 Jan.
Article
in English
| MEDLINE | ID: mdl-27783866
16.
Podoplanin promotes progression of malignant pleural mesothelioma by regulating motility and focus formation.
Cancer Sci
; 108(4): 696-703, 2017 Apr.
Article
in English
| MEDLINE | ID: mdl-28182302
17.
The crystal structure of an inverting glycoside hydrolase family 9 exo-ß-D-glucosaminidase and the design of glycosynthase.
Biochem J
; 473(4): 463-72, 2016 Feb 15.
Article
in English
| MEDLINE | ID: mdl-26621872
18.
Organ-specific efficacy of HSP90 inhibitor in multiple-organ metastasis model of chemorefractory small cell lung cancer.
Int J Cancer
; 138(5): 1281-9, 2016 Mar 01.
Article
in English
| MEDLINE | ID: mdl-26379118
19.
Protective efficacy of Babesia gibsoni culture-derived exoantigens against the challenge infection in dogs.
Parasitol Res
; 113(5): 1681-6, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24535736
20.
Targeting WEE1 enhances the antitumor effect of KRAS-mutated non-small cell lung cancer harboring TP53 mutations.
Cell Rep Med
; 5(6): 101578, 2024 Jun 18.
Article
in English
| MEDLINE | ID: mdl-38776912